Community-reported Revlimid side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Revlimid Side Effect
Have You dealt with a Revlimid side effect? Share your experience
Review Revlimid Safety Reports submitted to FDA
Total Revlimid reports: 5063.Revlimid FDA safety alerts: No.
Reported deaths: 1967 Reported hospitalizations: 1610.
Take Revlimid Side Effects Survey, Discuss Revlimid with others
FDA Reported Revlimid Side Effects: death, disease progression, multiple myeloma, malignant neoplasm progression, fatigue, myelodysplastic syndrome, platelet count decreased, asthenia, pancytopenia, thrombocytopenia, white blood cell count decreased.
Revlimid Usage.
If you have questions about Revlimid, you can ask a Health Expert or Ask Patient Community about Revlimid.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
< Previous Showing 201-300 of 5063 Next >
Revlimid Side Effects Report #5691464-4Physician from UNITED STATES reported REVLIMID problem on Mar 26, 2008. Female patient, 79 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma. REVLIMID dosage: unknown. Patient was hospitalized. Patient died on 02/07/2008.
Revlimid Side Effects Report #5691465-6
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 26, 2008. Male patient, 72 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cardiac failure congestive, disease progression. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. During the same period patient was treated with SYNTHROID, PEPCID, VITAMIN, AMBIEN, BENICAR, LANOXIN, ASPIRIN, TERAZOSIN. Patient was hospitalized. Patient died on 03/06/2008.
Revlimid Side Effects Report #5691466-8
Physician from UNITED STATES reported REVLIMID problem on Mar 24, 2008. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: haemorrhage. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5614975-6
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 25, 2008. Female patient, 79 years of age, was diagnosed with myeloproliferative disorder and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: presyncope, thrombocythaemia. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with TRIAMTERENE, PREMARIN, CALCIUM, VITAMIN, PROTONIX, MEGACE, PREDNISONE, HYDREA. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5614976-8
Physician from UNITED STATES reported REVLIMID problem on Jan 28, 2008. Male patient, 65 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5614978-1
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cerebral thrombosis. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 11/11/2007.
Revlimid Side Effects Report #5615006-4
Physician from UNITED STATES reported REVLIMID problem on Jan 25, 2008. Female patient, 78 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arrhythmia, dizziness, nasopharyngitis. REVLIMID dosage: 20 MG, DAILY X21 DAYS, ORAL, 15 MG, DAILY X21 DAYS, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5615008-8
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 28, 2008. Female patient, 65 years of age, was diagnosed with 5q-syndrome and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5615009-X
Health Professional from UNITED STATES reported REVLIMID problem on Jan 28, 2008. Male patient, 82 years of age, was diagnosed with multiple myeloma, neoplasm and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, platelet count decreased. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL, 10 MG, 1 IN 1 D, ORAL. Patient died on 01/15/2008.
Revlimid Side Effects Report #5615295-6
REVLIMID problem was reported by a Health Professional from UNITED STATES on Jan 25, 2008. Male patient, 69 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: convulsion, transient ischaemic attack. REVLIMID dosage: 10 MG, ORAL; 25 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5615311-1
Consumer or non-health professional from FRANCE reported REVLIMID problem on Jan 24, 2008. Male patient, 54 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: lung disorder, renal failure. REVLIMID dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5616223-X
REVLIMID problem was reported by a Physician from FRANCE on Jan 25, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: hyperthyroidism, neutropenia. REVLIMID dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5618514-5
Physician from UNITED STATES reported REVLIMID problem on Jan 25, 2008. Male patient was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: eye swelling. REVLIMID dosage: unknown. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5618516-9
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2008. Male patient, 89 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac disorder. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5618517-0
Physician from UNITED STATES reported REVLIMID problem on Jan 29, 2008. Female patient, 63 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. REVLIMID dosage: unknown. Patient died on 12/03/2007.
Revlimid Side Effects Report #5618518-2
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 30, 2008. Male patient was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, sepsis. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 12/01/2007.
Revlimid Side Effects Report #5618520-0
Physician from UNITED STATES reported REVLIMID problem on Jan 29, 2008. Male patient, 81 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: sepsis. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 12/17/2007.
Revlimid Side Effects Report #5618521-2
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: lower limb fracture. REVLIMID dosage: 15 MG, QD, ORAL : 25 MG, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5618522-4
Physician from UNITED STATES reported REVLIMID problem on Jan 29, 2008. Female patient, 70 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DECADRON. Patient died on 12/16/2007.
Revlimid Side Effects Report #5618523-6
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2008. Male patient, 78 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/16/2008.
Revlimid Side Effects Report #5618524-8
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Jan 29, 2008. Male patient, 71 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 5 MG, QD, ORAL. Patient died on 01/04/2008.
Revlimid Side Effects Report #5618525-X
REVLIMID problem was reported by a Health Professional from UNITED STATES on Jan 29, 2008. Female patient, 70 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma. REVLIMID dosage: 5 MG, QD X 21 DAYS, ORAL. Patient died on 12/31/2007.
Revlimid Side Effects Report #5618526-1
Physician from UNITED STATES reported REVLIMID problem on Jan 29, 2008. Female patient, 84 years of age, was diagnosed with amyloidosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, disease progression, renal failure. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 12/26/2007.
Revlimid Side Effects Report #5618545-5
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2008. Male patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: multiple myeloma. REVLIMID dosage: unknown. Patient died on 01/09/2008.
Revlimid Side Effects Report #5618710-7
Physician from UNITED STATES reported REVLIMID problem on Jan 30, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5618711-9
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Feb 05, 2008. Male patient, 86 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: infection, pancytopenia. REVLIMID dosage: 25 MG EVERY OTHER DAY PO. Patient recovered.
Revlimid Side Effects Report #5618713-2
Physician from UNITED STATES reported REVLIMID problem on Jan 30, 2008. Male patient, 43 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with REVLIMID. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 09/01/2007.
Revlimid Side Effects Report #5618714-4
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 30, 2008. Male patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/15/2008.
Revlimid Side Effects Report #5618723-5
Physician from UNITED STATES reported REVLIMID problem on Jan 30, 2008. Female patient, 77 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/20/2008.
Revlimid Side Effects Report #5618726-0
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Female patient, 90 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5618727-2
Physician from UNITED STATES reported REVLIMID problem on Jan 31, 2008. Female patient, 52 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression. REVLIMID dosage: 20 MG, DAILY FOR 21 DAYS, ORAL. Patient died on 01/24/2008.
Revlimid Side Effects Report #5618728-4
REVLIMID problem was reported by a Health Professional from UNITED STATES on Jan 30, 2008. Male patient, 69 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, platelet disorder. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/25/2008.
Revlimid Side Effects Report #5618730-2
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Jan 30, 2008. Male patient, 32 years of age, was diagnosed with lymphoma and was treated with REVLIMID. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2008.
Revlimid Side Effects Report #5618731-4
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Male patient, 74 years of age, was diagnosed with chromosome analysis abnormal, multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, gastrointestinal haemorrhage, malignant neoplasm progression, multiple myeloma, renal failure, respiratory failure. REVLIMID dosage: 10 MG DAILY ORAL; 15 MG DAILY ORAL ; 25 MG DAILY ORAL. During the same period patient was treated with LOVENOX, WARFARIN. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5618784-3
Physician from UNITED STATES reported REVLIMID problem on Jan 29, 2008. Female patient, 76 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute leukaemia, haemoglobin decreased, neutropenia. REVLIMID dosage: 5 MG, DAILY, ORAL : 10 MG, DAILY, ORAL. During the same period patient was treated with TOPROL, SYNTHROID, NEXIUM, CALCITONIN, BENICAR. Patient died on 01/09/2008.
Revlimid Side Effects Report #5618801-0
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Male patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, paralysis. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DEXAMETHASONE, ZOMETA. Patient was hospitalized. Patient died on 11/23/2007.
Revlimid Side Effects Report #5618802-2
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Jan 28, 2008. Female patient, 80 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, musculoskeletal pain, sepsis. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL : X21 DAYS/28 DAYS, ORAL. Patient died on 01/04/2008.
Revlimid Side Effects Report #5618811-3
REVLIMID problem was reported by a Health Professional from UNITED STATES on Jan 25, 2008. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: haemorrhage. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5618812-5
Physician from UNITED STATES reported REVLIMID problem on Jan 28, 2008. Male patient, 72 years of age, weighting 175.0 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anaemia, arrhythmia, bacterial infection, cardiac disorder, neutropenia. REVLIMID dosage: 25 MG, DAILY FOR 21 DAYS, ORAL : 10 MG, DAILY FOR 21 DAYS, ORAL. During the same period patient was treated with VITAMIN B12, WARFARIN, ZOLOFT, DECADRON, AREDIA, ARANESP. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5618813-7
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Male patient, 81 years of age, was diagnosed with anaemia, myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: gastric infection, ill-defined disorder, intestinal obstruction. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5618814-9
Physician from UNITED STATES reported REVLIMID problem on Jan 25, 2008. Female patient, 50 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood human chorionic gonadotropin increased, treatment noncompliance. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL : 25 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5618840-X
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 28, 2008. Male patient, 49 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: multiple myeloma, neoplasm progression, renal failure acute. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 12/25/2007.
Revlimid Side Effects Report #5618843-5
Physician from UNITED STATES reported REVLIMID problem on Jan 28, 2008. Female patient, 78 years of age, weighting 108.9 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic decreased, blood urea increased, dizziness, dyspepsia, fatigue, headache, heart rate decreased, hypertension, light chain analysis increased. REVLIMID dosage: 25 MG, 1 IN1 D, ORAL. During the same period patient was treated with SYNTHROID, LEVAQUIN, LASIX, ATENOLOL, NIFEDIPINE ER, DIOVAN, ACYCLOVIR. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5618871-X
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 30, 2008. Female patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma. REVLIMID dosage: 10 - 15MG, DAILY X21 DAYS EVERY 28 DAYS, ORAL. Patient died.
Revlimid Side Effects Report #5619300-2
Health Professional from UNITED STATES reported REVLIMID problem on Feb 01, 2008. Male patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/26/2008.
Revlimid Side Effects Report #5619301-4
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 31, 2008. Male patient, 69 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2008.
Revlimid Side Effects Report #5619669-9
Physician from UNITED STATES reported REVLIMID problem on Jan 31, 2008. Male patient, 68 years of age, was diagnosed with cytogenetic analysis abnormal, multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, stent occlusion, thrombosis in device. REVLIMID dosage: 15 MG, DAILY X 21/28 DAYS, ORAL, 15 MG, DAILY, ORAL. During the same period patient was treated with DEXAMETHASONE, LIPITOR, ALLOPURINOL, LORAZEPAM, TRICOR. Patient recovered.
Revlimid Side Effects Report #5619670-5
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2008. Male patient, 75 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL; 10 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5619671-7
Health Professional from UNITED STATES reported REVLIMID problem on Feb 01, 2008. Male patient, 78 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5619672-9
REVLIMID problem was reported by a Health Professional from UNITED STATES on Feb 01, 2008. Male patient, 64 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 25 MG, QD X 21 DAYS, ORAL. Patient died.
Revlimid Side Effects Report #5619673-0
Pharmacist from UNITED STATES reported REVLIMID problem on Feb 01, 2008. Female patient, 73 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5619674-2
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 31, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2007.
Revlimid Side Effects Report #5619675-4
Physician from UNITED STATES reported REVLIMID problem on Jan 31, 2008. Male patient, 49 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: lymphoma, malignant neoplasm progression. REVLIMID dosage: 25 MG, QD X 3 WKS, ORAL. Patient died on 11/17/2007.
Revlimid Side Effects Report #5619676-6
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 31, 2008. Male patient, 74 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac disorder. REVLIMID dosage: 25 MG, QD 21 DAYS ON / 7 DAYS OFF, ORAL. Patient died on 12/01/2007.
Revlimid Side Effects Report #5619678-X
Physician from UNITED STATES reported REVLIMID problem on Jan 31, 2008. Male patient, 61 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: lung disorder. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 12/13/2007.
Revlimid Side Effects Report #5619679-1
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 31, 2008. Male patient, 78 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, myelodysplastic syndrome, pneumonia, pulmonary haemorrhage. REVLIMID dosage: 10 MG, DAILY, ORAL. Patient died on 12/29/2007.
Revlimid Side Effects Report #5619680-8
Physician from UNITED STATES reported REVLIMID problem on Jan 31, 2008. Male patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute leukaemia, disease progression, myelodysplastic syndrome. REVLIMID dosage: 10 MG, QD X 21 DAYS PER MONTH, ORAL; 5MG, 1 IN 1 D, ORAL; 2.5 MG, 1 IN 2 D, ORAL. Patient died on 12/30/2007.
Revlimid Side Effects Report #5622059-6
REVLIMID problem was reported by a Health Professional from SPAIN on Jan 30, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: face oedema, rash pruritic. REVLIMID dosage: 25 MG, DAILY, ORAL. Patient recovered.
Revlimid Side Effects Report #5622596-4
Health Professional from UNITED STATES reported REVLIMID problem on Feb 11, 2008. Male patient, 70 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: flushing, pain of skin, swelling face. REVLIMID dosage: 25MG PO DAILY. During the same period patient was treated with DECADRON. Patient recovered.
Revlimid Side Effects Report #5622931-7
REVLIMID problem was reported by a Physician from GERMANY on Jan 10, 2008. Female patient, 62 years of age, weighting 101.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, central line infection, diarrhoea, haematocrit decreased, haemoglobin decreased, haemorrhage, hypotension, idiopathic thrombocytopenic purpura. REVLIMID dosage: 25MG, DAILY 21/28, ORAL; 15 MG, 0-1-0-0, ORAL. During the same period patient was treated with DEXAMETHASONE, BACTRIM DS, PANTOPRAZOLE, ALLOPURINOL, VFEND, EUGALAC, AVELOX. Patient was hospitalized. Patient died on 01/06/2008.
Revlimid Side Effects Report #5622935-4
Health Professional from GERMANY reported REVLIMID problem on Jan 28, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, blood phosphorus decreased, blood potassium decreased, dehydration, diarrhoea, epilepsy, parkinsonism, restlessness, viral infection. REVLIMID dosage: unknown. During the same period patient was treated with DEXAMETHASONE, TAMSULOSIN, DIOVAN, NEXIUM, CIPRO, MOVICOL, ARANESP, FENTANYL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5622946-9
REVLIMID problem was reported by a Pharmacist from CANADA on Jan 31, 2008. Female patient was treated with REVLIMID. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5622947-0
Physician from GERMANY reported REVLIMID problem on Jan 30, 2008. Male patient was treated with REVLIMID. REVLIMID dosage: unknown. Patient died.
Revlimid Side Effects Report #5622987-1
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5622989-5
Health Professional from UNITED STATES reported REVLIMID problem on Jan 30, 2008. Male patient, 53 years of age, weighting 175.0 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, chest pain, coronary artery occlusion. REVLIMID dosage: 25 MG, DAILY X21 DAYS, ORAL. During the same period patient was treated with PLAVIX, SIMVASTATIN. Patient recovered.
Revlimid Side Effects Report #5622991-3
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Jan 30, 2008. Male patient, 59 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: back pain, fall, malignant neoplasm progression, multiple myeloma. REVLIMID dosage: unknown. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5623175-5
Physician from UNITED STATES reported REVLIMID problem on Jan 30, 2008. Male patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 01/15/2008.
Revlimid Side Effects Report #5623176-7
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 30, 2008. Female patient, 71 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, neuropathy peripheral, renal disorder, white blood cell count decreased. REVLIMID dosage: 15 MG, QD X 21 DAYS, ORAL; 10 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5623917-9
Physician from UNITED KINGDOM reported REVLIMID problem on Feb 01, 2008. Female patient was diagnosed with 5q-syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. REVLIMID dosage: 5 MG, DAILY, ORAL. Patient died on 11/13/2007.
Revlimid Side Effects Report #5624496-2
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Feb 01, 2008. Female patient, 65 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dizziness, gait disturbance, nervousness, pruritus. REVLIMID dosage: 10 MG, QD X 21 DAYS, ORAL. During the same period patient was treated with PROZAC, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5624502-5
Health Professional from UNITED STATES reported REVLIMID problem on Jan 30, 2008. Female patient, 80 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: hypoacusis. REVLIMID dosage: 10 MG, EVERY DAY FOR 21 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5624504-9
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 04, 2008. Female patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute leukaemia, diarrhoea, disease progression, myelodysplastic syndrome, purpura, thrombocytopenia. REVLIMID dosage: 2.5 MG, 1 IN 2 D, ORAL ; 5 MG, 1 IN 1 D ORAL. Patient died.
Revlimid Side Effects Report #5624512-8
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Jan 31, 2008. Female patient, 54 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: immune system disorder. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5624525-6
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 31, 2008. Female patient was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac pacemaker insertion, contusion, post procedural complication. REVLIMID dosage: 5 MG, DAILY, ORAL; 3X WEEKLY ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5624540-2
Physician from UNITED STATES reported REVLIMID problem on Feb 04, 2008. Female patient, 84 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: platelet count decreased. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 10/17/2007.
Revlimid Side Effects Report #5624723-1
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 04, 2008. Female patient, 76 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/05/2008.
Revlimid Side Effects Report #5624724-3
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Jan 31, 2008. Male patient, 76 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: abscess, ill-defined disorder. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5624992-8
REVLIMID problem was reported by a Health Professional from GERMANY on Feb 01, 2008. Male patient, 69 years of age, weighting 238.1 lb, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: back pain, blood bilirubin increased, bone pain, gamma-glutamyltransferase increased, haemoglobin decreased, jaundice, thrombocytopenia. REVLIMID dosage: 25 MG, DAILY, ORAL. During the same period patient was treated with ANTICOAGULANT. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5625158-8
Health Professional from SPAIN reported REVLIMID problem on Feb 06, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: face oedema, pruritus, rash. REVLIMID dosage: 25 MG, DAILY, ORAL. Patient recovered.
Revlimid Side Effects Report #5625188-6
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Feb 01, 2008. Female patient was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: fall, respiratory arrest. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5625189-8
Physician from UNITED STATES reported REVLIMID problem on Feb 01, 2008. Female patient, 74 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: autoimmune thrombocytopenia. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with STEROID. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5625327-7
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 04, 2008. Female patient, 84 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: renal failure. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 09/04/2007.
Revlimid Side Effects Report #5625328-9
Physician from UNITED STATES reported REVLIMID problem on Feb 04, 2008. Male patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelodysplastic syndrome, respiratory arrest. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 11/07/2007.
Revlimid Side Effects Report #5625329-0
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 01, 2008. Female patient, 47 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood human chorionic gonadotropin increased. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL; 15 MG,1 IN 1 D, ORAL; 12.5 MG, 1 IN 2 D, ORAL; 25 MG, 1 IN 1 D, ORAL; ORAL. Patient recovered.
Revlimid Side Effects Report #5625330-7
Physician from UNITED STATES reported REVLIMID problem on Feb 04, 2008. Male patient, 66 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 20 MG, 2 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5625745-7
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Feb 07, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: pancytopenia, pneumonia. REVLIMID dosage: 25MG DAILY X21D/28D PO. During the same period patient was treated with DEXAMETHASONE, HYDROMORPHONE, ALLOPURINOL, ACETAMINOPHEN AND HYDROCODONE BITARTRATE, PROCRIT, FENTANYL, NOVOLIN N. Patient recovered.
Revlimid Side Effects Report #5627619-4
Pharmacist from UNITED STATES reported REVLIMID problem on Feb 14, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: oedema peripheral. REVLIMID dosage: 15MG QD PO. Patient recovered.
Revlimid Side Effects Report #5628978-9
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 07, 2008. Male patient, 80 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: lymphoma, malignant neoplasm progression. REVLIMID dosage: unknown. Patient died on 02/07/2008.
Revlimid Side Effects Report #5628979-0
Physician from UNITED STATES reported REVLIMID problem on Feb 07, 2008. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, disease progression, escherichia sepsis, fall, myelodysplastic syndrome, neutropenic sepsis, pollakiuria, refusal of treatment by patient, renal failure. REVLIMID dosage: 10 MG, 21 DAYS OF 28 DAYS, ORAL. During the same period patient was treated with DECITABINE, PRBC, CHLORIDE. Patient died on 10/07/2007.
Revlimid Side Effects Report #5628980-7
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 08, 2008. Female patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disorientation, dizziness, headache. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2004.
Revlimid Side Effects Report #5628981-9
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Feb 08, 2008. Male patient, 77 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: full blood count decreased, pneumonia. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 12/01/2007.
Revlimid Side Effects Report #5628982-0
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 05, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bronchitis, convulsion, groin abscess, muscle spasms, myalgia, nausea, neuropathy peripheral, neutropenia, viral infection. REVLIMID dosage: unknown. During the same period patient was treated with ZANTAC, ARANESP, SPIRA, PLAVIX, LISINOPRIL. Patient recovered.
Revlimid Side Effects Report #5629005-X
Physician from UNITED STATES reported REVLIMID problem on Sept 07, 2007. Male patient, 57 years of age, weighting 204.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: abdominal pain, asthenia, back pain, blood lactate dehydrogenase increased, condition aggravated, hyperphosphataemia, hyperuricaemia. REVLIMID dosage: 25 MG, QD, ORAL. During the same period patient was treated with PREDNISONE, CORTICOSTEROIDS, PLATELETS, PACKED RED BLOOD CELLS, ATENOLOL, PRILOSCE, OXYCODONE, ALLOPURINOL. Patient was hospitalized. Patient died on 02/13/2007.
Revlimid Side Effects Report #5629009-7
REVLIMID problem was reported by a Health Professional from UNITED STATES on Feb 08, 2008. Male patient, 73 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/29/2008.
Revlimid Side Effects Report #5629410-1
Health Professional from UNITED STATES reported REVLIMID problem on Feb 15, 2008. Female patient, 53 years of age, weighting 97.44 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: colitis, constipation, rectal haemorrhage. REVLIMID dosage: 25MG QD PO. During the same period patient was treated with DECADRON, ASPIRIN. Patient recovered.
Revlimid Side Effects Report #5630324-1
REVLIMID problem was reported by a Health Professional from UNITED STATES on Feb 05, 2008. Male patient, 84 years of age, weighting 154.0 lb, was diagnosed with multiple myeloma, metastases to bone and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anaemia, fatigue, metastases to bone, platelet count decreased, renal failure. REVLIMID dosage: 20 MG, DAILY X 21 DAYS OUT OF 28, ORAL. During the same period patient was treated with ZOMETA, ASPIRIN. Patient died.
Revlimid Side Effects Report #5630366-6
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Feb 05, 2008. Male patient, 83 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, disease progression, multiple myeloma. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL; 25 MG, 1 IN 1 D, ORAL ; 10 MG, 1 IN 1 D ORAL. Patient died on 01/28/2008.
Revlimid Side Effects Report #5630367-8
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2008. Male patient, 77 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood count abnormal, pneumonia. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5630386-1
Health Professional from UNITED STATES reported REVLIMID problem on Feb 04, 2008. Male patient, 81 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: heart rate irregular. REVLIMID dosage: 10 MG, QD X 28 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5630387-3
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 05, 2008. Female patient, 82 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, hepatic failure, multiple myeloma. REVLIMID dosage: 25 MG, QD, MULTIPLE CYCLES, ORAL. Patient died on 12/23/2007.
< Previous Showing 201-300 of 5063 Next >